MedCap president pleads guilty to huge private-placement fraud

MAY 13, 2012
It looks like jail time for a former principal of Medical Capital Holdings Inc., the firm behind the fraudulent private placements that destroyed dozens of broker-dealers and wiped out almost $1 billion in investor cash. Former Medical Capital president Joseph J. Lampariello last Monday pleaded guilty to wire fraud and faces up to 21 years in federal prison and an order to pay $49 million in restitution, according to a report in The Orange County Register. The press report stated that the plea agreement was filed under seal in U.S. District Court in the Central District of California. Calls placed last Tuesday to Mr. Lampariello's attorney, Amy Karlin, to confirm the report weren't returned. Assistant U.S. Attorney Jennifer Waier didn't return calls. Thomas Mrozek, a spokesman for the U.S. Attorney's Office in Los Angeles, declined to comment. Between 2003 and 2009, Medical Capital raised almost $2 billion by selling private notes, purportedly to buy discounted medical receivables such as unpaid doctor or hospital bills that the firm would collect at full price. A court-appointed receiver later charged that Medical Capital was a “Ponzi-like scheme” that resulted in about $1 billion in losses for 12,000 investors.

WIPED OUT

Dozens of independent broker-dealers sold MedCap notes. Many have since gone out of business due to massive costs from lawsuits by investors looking to regain money lost in the fraud. Medical Capital's former chief executive, Sidney Field, hasn't been criminally charged. Both Mr. Field and Mr. Lampariello, 58, were sued by the Securities and Exchange Commission in July 2009 for fraud in their running of Medical Capital's last offering, Medical Provider Funding Corp. VI, known as MedCap VI in the brokerage industry. That case was later closed in order for criminal proceedings to continue. According to the Justice Department's information filing against Mr. Lampariello last month, he defrauded the note holders of MedCap VI from August 2008 until June 2009. Investors were told that the proceeds raised by MedCap VI would be used to purchase account receivables, make loans, pay sales commissions and other costs, and provide funds for general operating purposes, according to the filing. In fact, Mr. Lampariello and others “misappropriated investor funds” in order to “make Ponzi-type payments to note holders from earlier” partnerships and to pay fees to Medical Capital. He caused MedCap VI note holders to lose about $39 million, according to the filing. Mr. Lampariello, according to a separate federal charge, “earned $6.2 million from MedCap from 2004 through 2008, including $1.47 million in 2008 alone, but failed to file federal tax returns. On Monday, he pleaded guilty to a single count of failing to file a tax return in 2008,” The Orange County Register reported. When the SEC took over, the company reportedly owned a medical nuclear reactor and two closed hospitals that had lost their operating licenses. MedCap also was reportedly involved in producing a feature-length movie about a Mexican Little League team. [email protected]

Latest News

Private credit becoming 'big piece' of annuities, T. Rowe exec says
Private credit becoming 'big piece' of annuities, T. Rowe exec says

Goldman Sachs retirement survey finds 83% want guaranteed income, while the annuities providing that income increasingly hold private credit.

Zocks debuts Claude plugin with seven skills for financial advisors
Zocks debuts Claude plugin with seven skills for financial advisors

The AI meeting assistant's Advisor Intelligence plugin turns client conversation data into annual reviews, tax scans and attrition alerts.

Stifel settles massive $30 million complaint involving star broker’s sale of structured products
Stifel settles massive $30 million complaint involving star broker’s sale of structured products

Chuck Roberts and Stifel have been facing scrutiny due to sales of structured products and structured notes.

SEC floats CFP route to accredited investor status, fund rules refresh amid private market push
SEC floats CFP route to accredited investor status, fund rules refresh amid private market push

Among other updates, the proposals would let advisors to regulated funds earn performance fees and allow interval funds to offer monthly repurchases.

The Year Is 2046 and I’m a Financial Advisor 
The Year Is 2046 and I’m a Financial Advisor 

What will financial advice look like 20 years from now? Evan Vladem explores how AI may transform wealth management while reinforcing the enduring value of human guidance, trust, and empathy. 

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor

SPONSORED Direct indexing webinar targets tax-loss harvesting amid market swings

Northern Trust’s Ken Lassner shows advisors how to convert volatility into after-tax portfolio gains